The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern?
Abstract
BACKGROUND AND PURPOSE: Optic nerve involvement is frequent in mitochondrial disease, and retinal abnormalities are described in Parkinson's disease (PD). METHODS: We evaluated retinal nerve fiber layer (RNFL) thickness by optical coherence tomography in 43 patients with PD and in 86 age-matched controls. We considered separately the eyes ipsilateral and contralateral to the most affected body side in patients with PD. ancova analysis, Pearson test, and multiple regression analysis were used (P < 0.05). RESULTS: Patients with PD showed significantly thinner temporal RNFL thickness compared to controls (P = 0.004), more evident in the eye contralateral to the most affected body side. Average RNFL thickness significantly correlated with age in both controls and patients with PD (P-values ranging from 0.001 to 0.019), whereas in patients with PD RNFL thickness did not correlate with clinical variables. CONCLUSIONS: Our study reveals a loss of retinal nerve fibers in the temporal quadrant in PD, which is typically susceptible in mitochondrial optic neuropathies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, abnormalities in visual function have been reported (Bodis-Wollner, 1990; Nowacka et al., 2014) in PD patients and correlated with changes in retinal tissue (La Morgia et al., 2013; Yu et al., 2014) (Table 1).”
From The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma. (2017) · cites this paper as La Morgia et al., 2013
Citations
Cites
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883
Retinal nerve fiber layer thinning in Parkinson disease
Inzelberg, R., Ramirez, J. A., Nisipeanu, P., & Ophir, A. (2004) · Vision Research · doi:10.1016/j.visres.2004.06.009 · Cited by 343 · cited 1×
“Optic nerve pathology in PD has been previously documented by others, some reporting a preferential loss of fibers in the infero-temporal quadrants, consistent with the involvement of the papillomacular bundle [9,10,13].”
ResultInner Retinal Layer Thinning in Parkinson Disease
Hajee, M. E. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.106 · Cited by 269
Barboni, P., Savini, G., Valentino, M. L., Montagna, P., Cortelli, P., DeNegri, A. M., Sadun, F., BIANCHI, S., Longanesi, L., & Zanini, M. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2004.06.034 · Cited by 246
Nonmotor manifestations of Parkinson's disease
Simuni, T., & Sethi, K. D. (2009) · Annals of Neurology · doi:10.1002/ana.21472 · Cited by 242
Altıntaş, Ö., İşeri, P., Özkan, B., & Çağlar, Y. (2007) · Documenta Ophthalmologica · doi:10.1007/s10633-007-9091-8 · Cited by 240
Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders
Carelli, V., Morgia, C. L., Valentino, M. L., Barboni, P., Ross‐Cisneros, F. N., & Sadun, A. A. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.02.024 · Cited by 238
Barboni, P., Carbonelli, M., Savini, G., Ramos, C. D. V. F., Carta, A., Berezovsky, A., Salomão, S. R., Carelli, V., & Sadun, A. A. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.07.026 · Cited by 214
Cited by
Sorted by citations
Visual dysfunction in Parkinson’s disease
Weil, R. S., Schrag, A. E., Warren, J. D., Crutch, S. J., Lees, A. J., & Morris, H. R. (2016) · Brain · doi:10.1093/brain/aww175 · Cited by 481
“Interocular differences are seen in retinal thickness in Parkinson’s disease (Shrier et al., 2012) with more thinning contralateral to the side of motor symptoms (La Morgia et al., 2013), consistent with an asymmetric process involving the eye on the same side as the affected substantia nigra.”
BackgroundResultThe role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma.
Ramirez, A. I., de Hoz, R., Salobrar-Garcia, E., Salazar, J. J., Rojas, B., Ajoy, D., López-Cuenca, I., Rojas, P., Triviño, A., & Ramírez, J. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00214 · Cited by 466
“Moreover, abnormalities in visual function have been reported (Bodis-Wollner, 1990; Nowacka et al., 2014) in PD patients and correlated with changes in retinal tissue (La Morgia et al., 2013; Yu et al., 2014) (Table 1).”
BackgroundRetinal Nerve Fiber Layer Thickness Changes in Parkinson Disease: A Meta-Analysis
Yu, J.-G., Feng, Y.-F., Xiang, Y., Huang, J.-H., Savini, G., Parisi, V., Yang, W.-J., & Fu, X.-A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085718 · Cited by 200
“Two studies were done in Greece [5,21], 3 in Turkey [6,19,23], 2 in Spain [17,24], 1 each in Iran [20], Italy [22], USA [9], United Kingdom [7], Israel [18] and Germany [4].”
BackgroundPast, present and future role of retinal imaging in neurodegenerative disease
Kashani, A. H., Asanad, S., Chan, J. W., Singer, M., Zhang, J., Sharifi, M., Khansari, M. M., Abdolahi, F., Shi, Y., Biffi, A., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100938 · Cited by 169
García‐Martín, E., Larrosa, J. M., Polo, V., Satué, M., Marques, M. L., Alarcia, R., Seral, M., Fuertes, I., Otín, S., & Pablo, L. E. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.09.028 · Cited by 155
“A recent improvement in OCT technology is the prototype of specific software that allows for automatic differentiation and quantification of the 10 retinal layers using the Spectralis OCT.”
BackgroundInfluential
Metadata
- Authors
- La Morgia, C., Barboni, P., Rizzo, G., Carbonelli, M., Savini, G., Scaglione, C., Capellari, S., Bonazza, S., Giannoccaro, M. P., Calandra‐Buonaura, G., Liguori, R., Cortelli, P., Martinelli, P., Baruzzi, A., & Carelli, V.
- Affiliations
- University of Bologna (IT)
- Istituto delle Scienze Neurologiche di Bologna (IT)
- Fondazione G.B. Bietti (IT)
- ORCID
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2012-03-21
- Volume
- 20
- Issue
- 1
- Pages
- 198-201
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W2152613502
- Cited by
- 110
- References
- 18
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 4 · 2023: 7 · 2022: 9 · 2021: 11 · 2020: 13 · 2019: 12 · 2018: 9 · 2017: 10 · 2016: 10 · 2015: 4 · 2014: 5 · 2013: 6 · 2012: 3
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Ophthalmology › Drug-Induced Ocular Toxicity
- Keywords
- Parkinson's disease, retinal nerve fiber layer thickness, temporal quadrant, mitochondrial optic neuropathy, mitochondrial disease, optic nerve involvement, retinal abnormalities, fellow eye
- MeSH terms
- Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Mutation, Nerve Fibers, Optic Nerve, Optic Nerve Diseases, Parkinson Disease, Retina, Case-Control Studies, Protein Serine-Threonine Kinases, Tomography, Optical Coherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
